The combined biomarker [TIMP-2]•[IGFBP7] has demonstrated strong predictive ability for AKI in large, diverse cohorts, including the Sapphire, Opal, and Topaz studies [11, 13, 14]. This evidence concerns the gene TIMP2 and acute kidney injury.